Cargando…
Multifocal Femto-PresbyLASIK in Pseudophakic Eyes
Background: Presbyopia treatment in pseudophakic patients with a monofocal IOL is challenging. This study investigates the refractive results of femto-PresbyLASIK and analyzes presbyopia treatment in pseudophakic eyes. Methods: 14 patients with 28 pseudophakic eyes were treated with femto-PresbyLASI...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197358/ https://www.ncbi.nlm.nih.gov/pubmed/34070242 http://dx.doi.org/10.3390/jcm10112282 |
_version_ | 1783706901523988480 |
---|---|
author | Pajic, Bojan Massa, Horace Baenninger, Philipp B. Eskina, Erika Pajic-Eggspuehler, Brigitte Resan, Mirko Cvejic, Zeljka |
author_facet | Pajic, Bojan Massa, Horace Baenninger, Philipp B. Eskina, Erika Pajic-Eggspuehler, Brigitte Resan, Mirko Cvejic, Zeljka |
author_sort | Pajic, Bojan |
collection | PubMed |
description | Background: Presbyopia treatment in pseudophakic patients with a monofocal IOL is challenging. This study investigates the refractive results of femto-PresbyLASIK and analyzes presbyopia treatment in pseudophakic eyes. Methods: 14 patients with 28 pseudophakic eyes were treated with femto-PresbyLASIK. The dominant eye was targeted at a distance and the non-dominant eye at −0.5 D. The presbyopic algorithm creates a steepness in the cornea center by using an excimer laser that leads to corneal multifocality. Results: 6 months after surgery a refraction of −0.11 ± 0.13 D (p = 0.001), an uncorrected distance visual acuity of 0.05 ± 1.0 logMAR (p < 0.001) and an uncorrected near visual acuity of 0.15 ± 0.89 logMAR (p = 0.001) were achieved in the dominant eye. For the non-dominant eye, the refraction was −0.28 ± 0.22 D (p = 0.002), the uncorrected distance of visual acuity was 0.1 ± 1.49 logMAR, and the uncorrected near visual acuity was 0.11 ± 0.80 logMAR (p < 0.001). Spherical aberrations (Z400) were reduced by 0.21–0.3 µm in 32% of eyes, and by 0.31–0.4 µm in 26% of eyes. Conclusion: By steepening the central cornea while maintaining spherical aberrations within acceptable limits, PresbyLASIK created a corneal multifocality that safely improved near vision in both eyes. Thus, femto-PresbyLASIK can be used to treat presbyopia in pseudophakic eyes without performing intraocular surgery. |
format | Online Article Text |
id | pubmed-8197358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81973582021-06-13 Multifocal Femto-PresbyLASIK in Pseudophakic Eyes Pajic, Bojan Massa, Horace Baenninger, Philipp B. Eskina, Erika Pajic-Eggspuehler, Brigitte Resan, Mirko Cvejic, Zeljka J Clin Med Article Background: Presbyopia treatment in pseudophakic patients with a monofocal IOL is challenging. This study investigates the refractive results of femto-PresbyLASIK and analyzes presbyopia treatment in pseudophakic eyes. Methods: 14 patients with 28 pseudophakic eyes were treated with femto-PresbyLASIK. The dominant eye was targeted at a distance and the non-dominant eye at −0.5 D. The presbyopic algorithm creates a steepness in the cornea center by using an excimer laser that leads to corneal multifocality. Results: 6 months after surgery a refraction of −0.11 ± 0.13 D (p = 0.001), an uncorrected distance visual acuity of 0.05 ± 1.0 logMAR (p < 0.001) and an uncorrected near visual acuity of 0.15 ± 0.89 logMAR (p = 0.001) were achieved in the dominant eye. For the non-dominant eye, the refraction was −0.28 ± 0.22 D (p = 0.002), the uncorrected distance of visual acuity was 0.1 ± 1.49 logMAR, and the uncorrected near visual acuity was 0.11 ± 0.80 logMAR (p < 0.001). Spherical aberrations (Z400) were reduced by 0.21–0.3 µm in 32% of eyes, and by 0.31–0.4 µm in 26% of eyes. Conclusion: By steepening the central cornea while maintaining spherical aberrations within acceptable limits, PresbyLASIK created a corneal multifocality that safely improved near vision in both eyes. Thus, femto-PresbyLASIK can be used to treat presbyopia in pseudophakic eyes without performing intraocular surgery. MDPI 2021-05-25 /pmc/articles/PMC8197358/ /pubmed/34070242 http://dx.doi.org/10.3390/jcm10112282 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pajic, Bojan Massa, Horace Baenninger, Philipp B. Eskina, Erika Pajic-Eggspuehler, Brigitte Resan, Mirko Cvejic, Zeljka Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title | Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title_full | Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title_fullStr | Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title_full_unstemmed | Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title_short | Multifocal Femto-PresbyLASIK in Pseudophakic Eyes |
title_sort | multifocal femto-presbylasik in pseudophakic eyes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197358/ https://www.ncbi.nlm.nih.gov/pubmed/34070242 http://dx.doi.org/10.3390/jcm10112282 |
work_keys_str_mv | AT pajicbojan multifocalfemtopresbylasikinpseudophakiceyes AT massahorace multifocalfemtopresbylasikinpseudophakiceyes AT baenningerphilippb multifocalfemtopresbylasikinpseudophakiceyes AT eskinaerika multifocalfemtopresbylasikinpseudophakiceyes AT pajiceggspuehlerbrigitte multifocalfemtopresbylasikinpseudophakiceyes AT resanmirko multifocalfemtopresbylasikinpseudophakiceyes AT cvejiczeljka multifocalfemtopresbylasikinpseudophakiceyes |